Hubungan kadar vitamin D plasma dengan IMT dan umur pada kanker payudara

Zakirullah Syafei* -  Prodi Keperawatan Langsa Poltekkes Kemenkes Aceh dan Magister Biomedik Fakultas Kedokteran Universitas Sumatera Utara, Indonesia
Sri W Suryani -  Magister Ilmu Biomedik, Fakultas Kedokteran, Universitas Sumatera Utara, dan RS Murni Teguh, Medan. Indonesia, Indonesia
Denny S Rifsal -  Magister Ilmu Biomedik, Fakultas Kedokteran, Universitas Sumatera Utara, dan RSUP-H Adam Malik, Medan. Indonesia, Indonesia
DOI : 10.30867/action.v3i2.110

Breast cancer is the most common type of cancer in women worldwide. Statistics show breast cancer is the second leading cause of death after lung cancer. Vitamin D is believed to have anti-carcinogenic properties independently effective in protecting against breast cancer, biologically active vitamin D, can inhibit cell proliferation, induction of differentiation and apoptosis and inhibit angiogenesis in normal and malignant breast cells. Basal metabolic index (BMI) affects the bioavailability of vitamin D. Also the incidence of cancer increases with age, especially the age group> 40 years. The objective to analyze the relationship of plasma vitamin D levels with BMI and age in breast cancer. Method shaped analytic observational study with a cross-sectional design. A total of 53 outpatient breast cancer patients at Medan General Hospital were selected as study subjects using consecutive sampling technique. Serum 25 (OH) D testing used an enzyme-linked immunoabsorbent assay method. BMI data is obtained by measuring the body weight and height and age of the respondents' interviews. Data analysis used Spearman correlation statistical test. Results,  the mean vitamin D levels of the study subjects were 28,2 ± 8,9 ng / mL, BMI 25,5 ± 4,6 kg / m2, and subject age 51.1 ± 10,2 years. These results indicate normal vitamin D levels, a slightly high BMI and> 40 years of age. Statistical test results showed that there was a relatively weak relationship between plasma vitamin D levels and BMI (r = 0,2; p = 0,42) and age (r = 0,15; p = 0,86) breast cancer patients. Conclusion, there was no significant relationship between plasma vitamin D levels and the metabolic basal index and age in breast cancer patients.


Kanker payudara merupakan jenis kanker yang paling umum terdapat pada wanita di seluruh dunia. Vitamin D memiliki sifat anti karsinogenik secara independen efektif dalam melindungi dari kanker payudara, secara biologis vitamin D aktif, dapat menghambat proliferasi sel, induksi deferensiasi dan apoptosis serta menghalangi angiogenesis pada sel payudara normal dan maligna. Indeks Masa Tubuh (IMT) berpengaruh terhadap bioavaibilitas vitamin D. Tujuan untuk menganalisis  hubungan kadar vitamin D plasma dengan IMT dan umur pada kanker payudara. Penelitian menggunakan studi observasional analitik dengan desain cross sectional. Sebanyak 53 pasien kanker payudara rawat jalan di RSUP-HAM Medan dipilih sebagai subjek penelitian menggunakan tehnik consecutive sampling. Pengujian serum 25(OH)D menggunakan metode enzyme-linked immunoabsorbent assay. Data IMT diperoleh dengan pengukuran berat badan dan tinggi badan serta umur dari hasil wawancara responden. Analisis data menggunakan uji statistik korelasi spearman.  Hasil, rerata kadar vitamin D subjek penelitian adalah 28,2±8,9 ng/mL, IMT 25,5±4,6 kg/m2, dan usia subjek 51,1±10,2 tahun. Hasil ini menunjukkan kadar vitamin D normal, IMT sedikit tinggi dan usia > 40 tahun. Hasil uji statistik, menunjukkan bahwa terdapat hubungan yang tergolong lemah antara kadar vitamin D plasma dengan IMT (r=0,2; p=0,42) dan usia (r=0,15; p=0,86) pasien kanker payudara. Kesimpulan, tidak terdapat hubungan yang signifikan antara kadar vitamin D plasma dengan indek masa tubuh dan usia  pada pasien kanker payudara.

Keywords : Kanker payudara; kadar vitamin D; IMT; umur

  1. Jaime G, Abelardo M, Garcia CA. Imflamatory breast cancer. Department of Medical Direction Instituto Nacional de Cancerología-Mexico, Mexico city. 2013;(3):4-8.
  2. Thorne J, Campbell MJ. The vitamin D receptor in cancer. The Proceedings of the Nutrition Society. 2008;67(2):115-127. doi:10.1017/S0029665108006964.
  3. Cui Y, Rohan TE. Vitamin D, Calcium, and Breast Cancer Risk: A Review. Cancer Epidemiol Biomarkers Prev. 2006;15(8):1427-1437. doi:10.1158/1055-9965.EPI-06-0075.
  4. Kawase T, Matsuo K, Suzuki T, Hirose K, Hosono S, Watanabe M, Inagaki M, Iwata H, Tanaka H, Tajima K. Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan. Cancer Science. 2010;101(5):1234-1240. doi:10.1111/j.1349-7006.2010.01496.x.
  5. Welsh JE, Wietzke JA, Zinser GM, Byrne B, Smith K, Narvaez CJ. Vitamin D-3 receptor as a target for breast cancer prevention. Journal of Nutrition. 2003;133(7):2425S-2433S.
  6. Colagar AH, Firouzjah HM, Halalkhor S. Breast Cancer Vitamin D Receptor Poly ( A ) Microsatellite Polymorphism and 25-Hydroxyvitamin D Serum Levels : Association with Susceptibility to Breast Cancer. 2015;18(2):119-125.
  7. Khan MI, Bielecka ZF, Najm MZ, Bartnik E, Czarnecki JS, Czarnecka AM, Szczylik C. Vitamin D receptor gene polymorphisms in breast and renal cancer: Current state and future approaches (Review). International Journal of Oncology. 2014;44(2):349-363. doi:10.3892/ijo.2013.2204.
  8. Köstner K, Denzer N, Müller CSL, Klein R, Tilgen W, Reichrath J. The relevance of Vitamin D Receptor (VDR) gene polymorphisms for cancer: A review of the literature. Anticancer Research. 2009;29(9):3511-3536. doi:29/9/3511 [pii].
  9. Tao MH, Shu XO, Zhi XR, Gao YT, Zheng W. Association of overweight with breast cancer survival. American Journal of Epidemiology. 2006;163(2):101-107. doi:10.1093/aje/kwj017.
  10. Rahmatya A, Khambri D, Mulyani H. Hubungan Usia dengan Gambaran Klinikopatologi Kanker. Jurnal Kesehatan Andalas. 2015;4(2):478-484.
  11. N Vilarrasa, Maravall J, Estepa A SR. Low 25-hydroxyvitamin D concentrations in obese women: their clinical significar and relationship with anthropometric and body composition variables. Journal of Endocrinology Investigation. 2007;30(8):653-658. doi:10.1007/BF03347445.
  12. Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG, Kamaci M. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Archives of Gynecology and Obstetrics. 2009;280(4):559-563. doi:10.1007/s00404-009-0958-7.
  13. La Vecchia C, Giordano SH, Hortobagyi GN, Chabner B. Overweight, Obesity, Diabetes, and Risk of Breast Cancer: Interlocking Pieces of the Puzzle. The Oncologist. 2011;16(6):726-729. doi:10.1634/theoncologist.2011-0050.
  14. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bas Bueno de Mesquita H, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). Journal of the National Cancer Institute. 2005;97(10):755-765. doi:10.1093/jnci/dji132.
  15. Tsiaras WG, Weinstock MA. Factors influencing vitamin d status. Acta Dermato-Venereologica. 2011;91(2):115-124. doi:10.2340/00015555-0980.
  16. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7(9):684-700. doi:nrc2196 [pii]r10.1038/nrc2196.
  17. Norman AW. Minireview: Vitamin D receptor: New assignments for an already
  18. busy receptor. Endocrinology. 2006;147(12):5542-5548. doi:10.1210/en.2006-0946.
  19. Nani D. Analisis Faktor-Faktor Yang Berhubungan Dengan Kejadian Kanker Payudara Di Rumah Sakit Pertamina Cilacap. Jurnal Keperawatan Soedirman. 2009;4(2):61-66.

Open Access Copyright (c) 2018 Zakirullah Syafei, Sri W Suryani, Denny S Rifsal
Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

AcTion: Aceh Nutrition Journal
Published by: Department of Nutrition at the Health Polytechnic of Aceh, Ministry of Health.
Soekarno-Hatta Street, No. 168. Health Polytechnic of Aceh, Aceh Besar, 23352. Telp/Fax: 0651 46126 / 0651 46121.
Website: https://gizipoltekkesaceh.ac.id/
E-mail: [email protected]

e-issn: 2548-5741, p-issn: 2527-3310

All content is licensed under a: Creative Commons Attribution ShareAlike 4.0 International License

View My Stats

Get a feed by atom here, RRS2 here and OAI Links here